LB Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | +100.0% | +2,175.0% | +252.7% | |
| – | -31.6% | +971.5% | +32.6% | |
| – | -1,626.7% | – | -512.0% | |
| – | – | +2,976.0% | -93.2% | |
| – | -22,872.4% | – | -271.7% | |
| – | -97.1% | -100.0% | – | |
| – | +46.7% | +13.8% | +689.7% | |
| – | -131.6% | – | +2,573.8% | |
| – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.